Erectile dysfunction in patients with liver disease related to chronic hepatitis B
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Despite sexual function making an important contribution to the quality of life, data on erectile function are relatively scant in patients with chronic liver disease. We evaluated the prevalence of and risk factors for erectile dysfunction (ED) in patients with liver disease related to hepatitis B, especially among those with chronic hepatitis B (CHB) or early-stage cirrhosis. Methods: In total, 69 patients (35 with CHB and 34 with hepatitis-B-related liver cirrhosis [HBV-LC]) aged 40–59 years were analyzed. Child-Pugh classes of A and B were present in 30 (88.2%) and 4 (11.8%) of the patients with HBV-LC, respectively. The erectile function of the patients was evaluated using the Korean version of IIEF-5. Results: The prevalence of any ED was 24.6% for all patients, and 8.6% and 41.2% for those with CHB and HBV-LC, respectively (P=0.002). While there was only one (2.9%) CHB patient for each stage of ED, mild, moderate, and severe ED stages were seen in three (8.8%), one (2.9%), and ten (29.4%) of the HBV-LC patients, respectively. Multiple regression analysis identified the type of liver disease (P=0.010), hypertension (P=0.022), score on the Beck Depression Inventory (P =0.044), and the serum albumin level (P=0.014) as significant independent factors for the presence of ED. Conclusions: The prevalence of ED was significantly higher in patients with early-stage HBV-LC than in those with CHB. Therefore, screening male patients with early viral cirrhosis for ED and providing appropriate support are needed, especially when the cirrhosis is accompanied by hypertension, depression, or a depressed level of serum albumin.
Abstract
Background/Aims: Despite sexual function making an important contribution to the quality of life, data on erectile function are relatively scant in patients with chronic liver disease. We evaluated the prevalence of and risk factors for erectile dysfunction (ED) in patients with liver disease related to hepatitis B, especially among those with chronic hepatitis B (CHB) or early-stage cirrhosis. Methods: In total, 69 patients (35 with CHB and 34 with hepatitis-B-related liver cirrhosis [HBV-LC]) aged 40–59 years were analyzed. Child-Pugh classes of A and B were present in 30 (88.2%) and 4 (11.8%) of the patients with HBV-LC, respectively. The erectile function of the patients was evaluated using the Korean version of IIEF-5. Results: The prevalence of any ED was 24.6% for all patients, and 8.6% and 41.2% for those with CHB and HBV-LC, respectively (P=0.002). While there was only one (2.9%) CHB patient for each stage of ED, mild, moderate, and severe ED stages were seen in three (8.8%), one (2.9%), and ten (29.4%) of the HBV-LC patients, respectively. Multiple regression analysis identified the type of liver disease (P=0.010), hypertension (P=0.022), score on the Beck Depression Inventory (P =0.044), and the serum albumin level (P=0.014) as significant independent factors for the presence of ED. Conclusions: The prevalence of ED was significantly higher in patients with early-stage HBV-LC than in those with CHB. Therefore, screening male patients with early viral cirrhosis for ED and providing appropriate support are needed, especially when the cirrhosis is accompanied by hypertension, depression, or a depressed level of serum albumin.
참고문헌 (18)
- Lue TF, "Erectile dysfunction", N Engl J Med, 342, pp.1802~1813 (2000)
- Ahn TY, "Prevalence and risk factors for erectile dysfunction in Korean men : results of an epidemiological study", J Sex Med, 4, pp.1269~1276 (2007)
- Cho BL, "Prevalence and risk factors for erectile dysfunction in primary care : results of a Korean study", Int J Impot Res, 15, pp.323~328 (2003)
- Gareri P, "Erectile dysfunction in the elderly : an old widespread issue with novel treatment perspectives", Int J Endocrinol, 2014, pp.878670~ (2014)
- Sorrell JH, "Sexual functioning in patients with endstage liver disease before and after transplantation", Liver Transpl, 12, pp.1473~1477 (2006)
- Huyghe E, "Erectile dysfunction in end-stage liver disease men", J Sex Med, 6, pp.1395~1401 (2009)
- Cornely CM, "Chronic advanced liver disease and impotence: cause and effect?", Hepatology, 4, pp.1227~1230 (1984)
- Karagiannis A, "Gonadal dysfunction in systemic diseases", Eur J Endocrinol, 152, pp.501~513 (2005)
- Wiesner RH, "MELD and PELD : application of survival models to liver allocation", Liver Transpl, 7, pp.567~580 (2001)
- Toda K, "Erectile dysfunction in patients with chronic viral liver disease : its relevance to protein malnutrition", J Gastroenterol, 40, pp.894~900 (2005)
- Simsek I, "Assessment of sexual functions in patients with chronic liver disease", Int J Impot Res, 17, pp.343~345 (2005)
- Gluud C, "No effect of oral testosterone treatment on sexual dysfunction in alcoholic cirrhotic men", Gastroenterology, 95, pp.1582~1587 (1988)
- Schiavi RC, "The relationship between pituitary-gonadal function and sexual behavior in healthy aging men", Psychosom Med, 53, pp.363~374 (1991)
- Smith PJ, "Sexual dysfunction with antihypertensive and antipsychotic agents", Clin Pharm, 5, pp.373~384 (1986)
- Fogari R, "Effect of antihypertensive agents on quality of life in the elderly", Drugs Aging, 21, pp.377~393 (2004)
- Keskin G, "Quality of life, depression, and anxiety among hepatitis B patients", Gastroenterol Nurs, 36, pp.346~356 (2013)
- Kloner R, "Erectile dysfunction and hypertension", Int J Impot Res, 19, pp.296~302 (2007)
- Mikhailidis DP, "The treatment of hypertension in patients with erectile dysfunction", Curr Med Res Opin, 16(1), pp.S31~S36 (2000)